Alzheimer’s disease is currently the largest unmet medical need in neurology. More than 44 million people live with dementia worldwide, with Alzheimer’s being the most common form. As aging populations expand, it is critical that better treatments become available. George Clinical is currently managing a clinical trial in Australia of a new drug whose preliminary […]
Read More
Throughout clinical trials, the data manager (DM) is heavily involved in constructing databases, managing reports, programming quality checks and managing the collection of data in the clinical trial. The DM is responsible for managing and training users the concepts of computerised clinical data base systems as well as fulfilling other duties such as design basic […]
Read More
New research from the International Childhood Cancer Cohort Consortium (I4C) confirms that childhood cancer is linked to birthweight. Childhood cancer appears to be slowly rising, at a rate of approximately 1% per year in developed countries. The I4C is an alliance of several large-scale studies of children that pools data on factors in relation to […]
Read More
The Malaysian government has committed funding to improve the healthcare systems in order to further support clinical research. Clinical Research Malaysia (CRM) is a non-profit organisation – wholly owned by the government of Malaysia, which intends to develop infrastructure for the Clinical Research Centre networks, and be able to support global industry sponsored research (ISR) […]
Read More
George Clinical (GC) conducted a brief survey on sponsors who are currently not a customer of GC. 30 companies were surveyed by GC’s Business Development Managers across six countries which included the United States, China, Australia, Korea, United Kingdom and Israel. The primary objective of the survey was to determine the services and countries that were important […]
Read More
The cost of employee turnover in a Clinical Research Organisation (CRO) is high, as it weakens the relationship with the project sponsor. Research shows that in 2012, the CRO industry in the United States experienced a 12.5% voluntary turnover, compared to an average national voluntary turnover rate of 1.5%. During the 2015 financial year, George Clinical […]
Read MoreIn a surprise move, the State Council in China has recently released a directive announcing its view on reforming the drug and medical device review and approval process in China. The State Council oversees the Chinese Food and Drug Administration (CFDA), and it is noteworthy that these changes were announced at a high level, reflecting […]
Read MoreGeorge Clinical in China recently celebrated its second anniversary as an independent entity in China. Although George Clinical has been conducting Phase 11 to Phase IV studies in China for over 8 years, previously it was incorporated into The George Institute in China – but now operates as a separate legal entity. The last two […]
Read MoreChina is a highly attractive clinical trial destination, and continues to see increased interest from CROs and drug development companies. China has a well-established tradition of developing medicines from basic research and the demands for modern pharmaceuticals is growing. Data gathered from clinicaltrials.gov indicated that in 2014, China had conducted 846 clinical trials, and an […]
Read MoreGeorge Clinical (GC) is at the heart of developing Asia Clinical Research Professionals. This summer, our Clinical and Regulatory Manager, East Asia volunteered as a trainer for Asia Training Consortium (ATC) in its Foundational Clinical Project Management training program in Hong Kong. ATC is a non-profit organisation aimed at providing a unified platform for industry […]
Read More
